T. Akcay et al., URINARY-EXCRETION OF GLYCOSAMINOGLYCANS IN PATIENTS WITH SUPERFICIAL BLADDER-TUMORS, Cancer biochemistry biophysics, 13(4), 1993, pp. 279-281
Urinary glycosaminoglycan/creatinine (GAG/Cr) ratio was determined in
73 patients with superficial bladder tumors and 34 healthy volunteers.
While the mean GAG/Cr value in the tumor group was higher than the co
ntrol group (11.25 +/- 5.36 vs. 10.11 +/- 2.67) this difference was no
t statistically significant. However, comparing the urinary GAG/Cr rat
io of T1, Grade III and recurrent tumors with the control group reveal
ed statistically significant results (p < 0.01, p < 0.001 and p < 0.02
respectively). Therefore, the urinary GAG/Cr ratio determination in t
he follow-up of these patients may be used as noninvasive procedure an
d high levels may be signs of higher grade, higher stage disease.